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Voltage-dependent anion channel (VDAC) proteins are major com-
ponents of the outer mitochondrial membrane. VDAC has three
isoforms with >70% sequence similarity and redundant roles in
metabolite and ion transport. However, only Vdac2−/− (V2−/−) mice
are embryonic lethal, indicating a unique and fundamental function
of VDAC2 (V2). Recently, a specific V2 requirement was demon-
strated for mitochondrial Bak import and truncated Bid (tBid)-
induced apoptosis. To determine the relevant domain(s) of V2
involved, VDAC1 (V1) and V2 chimeric constructs were created
and used to rescue V2−/− fibroblasts. Surprisingly, the commonly
cited V2-specific N-terminal extension and cysteines were found to
be dispensable for Bak import and high tBid sensitivity. In gain-of-
function studies, V2 (123–179) was the minimal sequence sufficient
to render V1 competent to support Bak insertion. Furthermore, in
loss-of-function experiments, T168 and D170 were identified as crit-
ical residues. These motifs are conserved in zebrafish V2 (zfV2) that
also rescued V2-deficient fibroblasts. Because high-resolution struc-
tures of zfV2 and mammalian V1 have become available, we could
superimpose these structures and recognized that the critical V2-
specific residues help to create a distinctive open “pocket” on the
cytoplasmic surface that could facilitate Bak recruitment.
mitochondria | VDAC2 | Bak | tBid | apoptosis
Voltage-dependent anion channel (VDAC) proteins providethe primary pathway for metabolite and ion flux through the
outer mitochondrial membrane (OMM) (1, 2). The VDAC has
three isoforms in vertebrates, which show >70% sequence simi-
larity and have a broad and overlapping tissue distribution. The
three isoforms can substitute for each other in the metabolite and
ion flux (2). However, they also have nonredundant roles in cell
function. Striking evidence of an isoform-specific role of VDAC2
(V2) is that embryos of homozygous deletion of Vdac2 alleles die
during development (3), whereas Vdac1−/− and Vdac3−/− mice are
viable and display mild phenotypes (4, 5). Thus, it is of great rel-
evance to determine the specific interactions and the underlying
structural arrangements of V2.
Recent evidence suggests that V2 is involved in Ca2+ transport
by cardiac mitochondria (6–8), and specifically interacts with sev-
eral endogenous cytoplasmic and mitochondria-associated pro-
teins, including steroidogenic acute regulatory protein (StAR) (9),
glycogen synthase kinase 3 beta (GSK3β) (10), O-GlcNAc trans-
ferase (11), ryanodine receptor 2 (8), tubulin (12), viral protein 5,
(13, 14), and drugs [erastin (15) and esfevin (7)]. These interactions
facilitate mitochondrial targeting, transport, and signaling pro-
cesses, and, interestingly, they seem to have striking effects on cell
survival. However, the most investigated interaction of V2 is with
Bak, a proapoptotic Bcl-2 family protein that is central to OMM
permeabilization, allowing the release of intermembrane space
proteins like cytochrome c (cyto c) and AIF to the cytosol to induce
apoptosis (16, 17).
OMM permeabilization can occur when death receptors like
TNF-α receptors are engaged and trigger caspase-8 activation to
cleave Bid, a BH3-only proapoptotic Bcl-2 family member. Re-
location of truncated Bid (tBid) (18, 19) to the OMM and in-
teraction with Bcl-2 family proteins (either proapoptotic and/or
antiapoptotic) lead to a conformational change and subsequent
homo-oligomerization or hetero-oligomerization of Bak (19, 20)
and another proapoptotic Bcl-2 family protein, Bax (21), pro-
viding the means of exit for intermembrane space proteins across
the OMM (22–24). At least in several cell types, the rapid ki-
netics of tBid-induced OMM permeabilization are primarily
dependent on Bak (25), presumably because Bak usually resides
in the OMM, whereas the mostly cytoplasmic Bax first needs to
translocate to the mitochondria (26, 27). Distribution of Bak
among individual mitochondria is uneven in cells lacking the
OMM fusion proteins Mfn1/2, indicating that OMM fusion is
required for Bak distribution (28). However, the availability of
Bak in the OMM is primarily controlled by insertion of Bak from
cytoplasm to the OMM.
Bak is a tail-anchored protein, but it is different from other
tail-anchored proteins like Bcl-2 or Bcl-xL in that unmasking of
its C-terminal tail domain and insertion to the mitochondria
require V2 (25, 29). In the OMM, Bak was also shown to asso-
ciate with V2 and to be part of a large complex (3). The interplay
between Bak and V2 is central to mitochondrial apoptosis and
might contribute to the vital significance of V2 (3, 25, 30–32).
Structural predictions of the VDAC family, primarily VDAC1
(V1) have been done using biochemical methods (33, 34) or
biophysical methods (i.e., NMR, crystallography) (35–39). These
studies uniformly suggest that VDACs are β-barrel–forming
transmembrane channels. Based on the biochemical studies, the
β-barrel is composed of one helix and 13 β-sheets with some
relatively long loops between β-sheets. In this model, the α-helix
is part of the wall of the channel. It had been proposed that the
long loops might play a role in protein–protein interaction (1).
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Differently, however, the biophysical studies show a β-barrel
formed by 19 β-sheets with the N-terminal α-helix lying inside the
pore. The α-helix is highly flexible and is likely to be associated
with VDAC channeling activity for the transfer of metabolites like
ATP (40, 41). The literature about the orientation of the VDACs
is divergent; however, a recent work by De Pinto and coworkers
(42) shows that the C terminus faces the intermembrane space.
The only crystallography study of V2 used zebrafish V2 (zfV2)
that had >90% sequence similarity to mammalian V2. This work
revealed few differences between V1 and V2, mostly confined to
the cytoplasmic loops (37).
In the present project, we have studied the domain(s) of V2 that
are necessary and/or sufficient for Bak targeting to the OMM and
Bak-mediated cyto c release. To this end, the few sequence dif-
ferences between mammalian V1 and V2 were systematically
analyzed by creating a series of chimeric constructs. The functional
activity of each construct was tested by evaluating the rescue of
Bak’s mitochondrial insertion and tBid-induced OMM per-
meabilization in Vdac2−/− (V2−/−) mouse embryonic fibroblasts
(MEFs). Our results demonstrate that previous suspects like the
N-terminal extension and high cysteine (C) content of V2 are ir-
relevant. Unexpectedly, the sequences of amino acids 168–171 and
123–179 represent the minimum domain of V2, which is necessary
and sufficient to provide for Bak import and rapid tBid-induced
apoptosis, respectively. In combination with the results of recent
structural studies, our findings allow us to propose a mechanism of
how the apparently minor sequence differences between V1 and
V2 can result in stark functional differences.
Results
Genetic Rescue of V2−/− MEFs Provides an Approach for Studying the
Requirements of Mitochondrial Bak Import and Cyto c Release. We
and others have provided evidence that Bak insertion to the OMM
and tBid-induced OMM permeabilization are supported only by
V2 among VDAC isoforms (25, 29, 30). To establish a paradigm
for determining the molecular basis for this nonredundant function
of V2, we used V2−/− MEFs and compared their Bak level and
their sensitivity to tBid-induced cell death under rescued and
nonrescued conditions. First, V2−/− MEFs were infected with V2-
adenovirus (avV2), and 36–48 h after the infection, the presence of
V2 was confirmed in the cells by immunoblotting membrane ly-
sates using a polyclonal anti-V2 antibody (Fig. 1A). This antibody
detects two bands at around 32–34 kDa in MEFs expressing V2;
however, only the upper band is relevant because it is the one that
is absent in the V2−/− MEFs and is restored in the genetically
rescued cells (arrow in Fig. 1A). Immunoblotting also showed Bak
in WT cells, which was low in V2−/− cells and was restored upon
rescue with avV2. Sensitivity of the cells to tBid was monitored by
studying cyto c release from mitochondria to cytosol. Blotting of
the membrane and cytosolic fractions against cyto c showed that
25 nM tBid for 5 min fails to release cyto c in V2−/−MEFs but causes
release in the rescued cells (Fig. 1B). Digitonin (600 μg/mL) was
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Fig. 1. Genetic rescue studies in V2−/− MEFs. Unique N-terminal extension in V2 is neither necessary nor enough for Bak import and cyto c release.
(A) Western blot verification of the presence of V2 and Bak in the membrane fraction of WT and V2−/− cells rescued with avV2. The arrow shows the relevant
band of V2. (B) Cyto c release was monitored by detecting the cyto c level in the membrane and cytosolic fraction of nonrescued (−) and avV2-rescued (+) V2−/−
permeabilized MEFs 5 min after treatment with solvent [tBid (25 nM) or digitonin (Dig, 600 μg/mL)]. TC, time control. Hsp70 and actin were used as loading
controls. (C) Representative traces for the time course of ΔΨm recorded in cell suspensions using a fluorometer. The experiment was carried out in permeabilized
V2−/− (black line) or avV2-rescued V2−/− (red line) cells treated with tBid or Dig (added at 300 s, marked by an arrow). FCCP (5 μM) was added at the end of the
recordings to dissipate the remaining ΔΨm. Data are presented as the percentage of the initial ΔΨm. TCs are the nontreated samples. (D) HA and Bak Western
blot of the membrane fraction of V2−/− cells transfected (tf) with HA-tagged V2, V2(Δ1–12), V1, or V2(1–12)V1. Immunoblot (E) and quantitative analysis (F) of
cyto c in the cytosolic fraction of V2−/− cells transfected with V2, V2(Δ1–12), V1, or V2(1–12)V1 and treated with tBid or Dig after plasma membrane per-
meabilization. In response to tBid, the cyto c band was normalized to the response to Dig in each condition (n = 3).
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used as a control to perforate the OMM and mobilize all of the
cyto c from mitochondria in both V2-deficient and rescued cells.
Because tBid-induced release of cyto c causes mitochondrial
membrane potential (ΔΨm) loss in the presence of oligomycin
(43), we recorded the ΔΨm in a suspension of permeabilized cells
using a fluorescent dye [tetramethylrhodamine methyl ester
(TMRM)] (Fig. 1C). In the V2−/− cells (black traces in Fig. 1C),
tBid addition did not change the ΔΨm, but in the rescued cells
(red traces in Fig. 1C), mitochondria responded to tBid by pro-
gressive depolarization. At the end of each experiment, a proto-
nophore [carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone
(FCCP)] was added to dissipate the ΔΨm completely. These re-
sults suggest that V2−/− MEFs provide a model allowing muta-
tional analysis of VDAC for Bak recruitment and tBid-induced
cyto c release. Furthermore, these findings extend the genetic
evidence on the critical role of V2 in mitochondrial Bak import
and tBid-induced rapid cyto c release.
Unique N-Terminal Extension in V2 Is Not Necessary for Bak Import
and Cyto c Release. To identify the motifs of V2 that are necessary
and/or sufficient for Bak import and tBid-induced OMM per-
meabilization, the protein sequence of V2 was systematically
compared with V1 and VDAC3 isoforms. The comparison showed
a unique 12-aa extension at the N-terminal end of V2 (Fig. S1A),
which is conserved in all mammals (Fig. S1B). To test the specific
contribution of this domain, the 12-aa extension was either re-
moved in the construct of V2-HA [called V2(Δ1–12)] or added to
N terminus of V1-HA [called V2(1–12)V1] (Fig. S2A). V2−/−
MEFs were cotransfected with the constructs described above,
and mitochondrial matrix-YFP. For negative control the cells
were transfected with only mitochondrial matrix-YFP. Forty-eight
hours later, cells were sorted on the basis of YFP fluorescence.
First, we validated the expression of the mutant VDAC proteins in
the sorted V2−/− cells using an anti-HA tag antibody (Fig. 1D,
Upper). Second, Bak recruitment was examined by immunoblot-
ting the membrane samples. The Bak level was increased in the
V2−/− cells transfected with V2 and V2(Δ1–12), whereas it was
similar to negative control in the cells expressing V1 and V2(1–12)
V1 (Fig. 1D, Lower).
Treatment of permeabilized cells with 25 nM tBid for 5 min
resulted in cyto c release in the fibroblasts expressing V2 and
V2(Δ1–12) but not in the cells expressing V1 or V2(1–12)V1 (Fig. 1
E and F). In addition, cyto c dynamics were monitored in the
cells cotransfected with V2, V2(Δ1–12), V1, and cyto c-GFP
using fluorescent microscopy. After applying 25 nM tBid, a sig-
nificant amount of cyto c was rapidly released in cells expressing
V2 or V2(Δ1–12) and there was no cyto c release in the cells
expressing V1 (Fig. S1C). Altogether, the data confirm that only
V2, and not V1, supports Bak targeting and tBid-induced mi-
tochondrial apoptosis effectively. In addition, the data indicate
that the 12-aa extension in the N terminus of V2 is not needed to
support Bak targeting and tBid-dependent cyto c release.
V2-Specific C’s Are Dispensable for Bak Import and tBid-Dependent
OMM Permeabilization. Comparison of amino acid sequences in
V1, V2, and VDAC3 revealed similar values for all residues except
C, which is exclusively higher in mammalian V2 (11 vs. 2 in V1 and
6 in V3). Localization of the C’s in the published biophysical
model of VDAC (35–38) showed that four of the C’s (48, 77, 104,
and 134; shown by blue arrows in Fig. 2A) in V2 are in the linkers
between β-sheets. They are seemingly at the same side of the V2
molecule and might be involved in protein–protein interaction
(Fig. 2A). To test their possible role in Bak recruitment, the four
linker-localized C’s (48, 77, 104, and 134) were mutated to as-
paragine (N) [called V2(4ΔC)] (Fig. S2B, Upper). Furthermore,
based on similarities between structures of V1 and V2 isoforms,
we also localized the C’s in the so-called “biochemical model” of
V1 (1, 34). In this model, two of the C’s (211 and 228) are in an
external loop of V2 (Fig. 2B). We hypothesized that a disulfide
bond between neighboring C’s in the loop might stabilize a suit-
able docking site for Bak or any relevant mediator protein.
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Therefore, in another mutant, C228 was replaced with its V1-
specific counterpart, which is N (N216) (Fig. S2B, Lower). Ex-
pression and the presence of the described mutants in the mem-
brane fraction of V2−/− cells expressing V2(4ΔC) and V2(C228N)
were confirmed using an anti-V2 antibody (Fig. 2C). V2−/− cells
expressing V2(4ΔC) or V2(C228N) showed recruitment of Bak
protein to the membrane (Fig. 2C) and were sensitized to tBid
(Fig. 2D), indicating that the C’s are not needed for the com-
petence of V2 to support Bak recruitment/tBid-induced cyto
c release.
zfV2 Rescues Bak Import and tBid-Induced OMM Permeabilization in
V2−/− MEFs. To examine further the effect of both the N-terminal
extension and the high numbers of C’s in the V2 sequence on the
OMM targeting of Bak, we used zfV2 (37). The zfV2 has 82%/
92% sequence identity/similarity with mouse V2 (mV2), but it
lacks the N-terminal extension and contains only one C at the
position of 127. HA-tagged mV2 and zfV2 were transfected in
V2−/− cells, and 48 h later, the proteins were detected in the
membrane fractions using HA antibody (Fig. 2E). Bak levels in
the membrane fraction were similarly elevated by zfV2 and mV2
rescue, indicating that zfV2 is capable of recruiting Bak. Fur-
thermore, treatment of the cells with 25 nM tBid caused similar
release of cyto c in the V2−/− cells expressing zfV2 and mV2 (Fig.
2F). Thus, studies of zfV2 further support that the N-terminal
extension and C’s are not critical for Bak targeting to the OMM.
Gain-of-Function Studies Using Chimeras of V1 and V2. As explained
above, the biochemical model (Fig. 2B) predicts a long cytoplas-
mic loop in the C-terminal third of V1 (34), which might be well
positioned to support unmasking of the tail of Bak. To find out
whether this domain is sufficient or required for Bak targeting,
four chimeras were generated. To test whether the loop is suffi-
cient, chimera 1 (Chi1) with the first two-thirds of V1 (1–185)
linked to the last third of V2 (198–295) was generated. To test
whether the loop is necessary, Chi3 with the first two-thirds of V2
(1–188) linked to the last third of V1 (177–283) was created. Chi2
was created by adding the 12 N-terminal residues to Chi1. Chi4
was created by deletion of this segment from Chi3 (Fig. S2C). V2−/−
MEF cells were transfected with the described chimeras, and the
presence of relevant proteins was confirmed in the membrane
fraction (Fig. 3A). The Bak level did not change in V2−/− cells
expressing Chi1 and Chi2, but it increased in the cells expressing
Chi3 and Chi4. Furthermore, rescue of tBid-induced cyto c release
was apparent only in the cells expressing Chi3 and Chi4 (Fig. 3B).
This evidence shows that the last one-third of V2 (198–295), in-
cluding the long external loop, is neither enough nor required for
the tBid/Bak OMM permeabilization pathway. On the other hand,
this result indicates that the domain relevant for Bak targeting to
the OMM is located between amino acid 12 and amino acid 188 of
V2. Therefore, in the next step, we generated two chimeras, Chi5
and Chi6, by substituting one-half of the V2-specific sequence of
Chi4 with the relevant sequence of V1 (Fig. S2D). In Chi5, V2
(13–118) of Chi4 was replaced with the relevant sequence of V1, and
in Chi6, V2 (119–188) of Chi4 was replaced with the relevant se-
quence of V1. The presence of the HA-tagged chimeric proteins in
the membrane fraction of V2−/− MEF cells expressing Chi5 and
Chi6 was confirmed (Fig. 3C). The Bak level increased in the
membrane fraction of cells expressing Chi5, but it was unaltered in
the cells expressing Chi6 (Fig. 3C). Consistently, tBid released cyto c
from V2−/− cells expressing only Chi5 (Fig. 3 D and E). This set of
data suggests that the domain that mediates targeting of Bak to
OMM is located in the middle domain of V2 (amino acids 119–188).
V2 (123–179) Is the Shortest Sequence Sufficient for Bak Recruitment.
To narrow the region sufficient for Bak import further, the se-
quence of V2 in Chi5 was compared with the relevant sequence of
V1. Based on clusters of different and not so similar amino acids
(using Clustal W nomenclature) in the V2 sequence, we generated
three constructs. In each of them, we substituted one-third of the
V2-specific middle domain in Chi5 with the corresponding se-
quence of V1. Specifically, in Chi 7–Chi 9, amino acids 119–137,
138–161, and 162–188 of the V2 sequence were replaced with
their V1 counterparts, respectively (Fig. S2E). Expression and
proper targeting of the chimeras were confirmed in V2−/− MEF
cells expressing Chi 7–Chi 9 (Fig. 4A). In the cells expressing Chi7
and Chi8, the Bak level increased in the membrane fraction, but it
did not change in the cells expressing Chi9. The tBid-induced
release of cyto c also occurred in the cells expressing Chi7 and
Chi8, but no release appeared in the cells expressing Chi9 (Fig.
4B). These data indicate that amino acid residues in the domain of
161–188 are needed for the Bak/cyto c release pathway. To test
whether this domain is sufficient for Bak recruitment, Chi10 was
generated with V2 (162–188) substituted for the relevant fragment
in V1 (Fig. S2E). This mutant was expressed in the V2−/− cells, but
it failed to support Bak recruitment (Fig. 4A) and cyto c release
after treatment with tBid (Fig. 4B). Thus, V2 (162–188) is essen-
tial, but not sufficient, for Bak targeting to the OMM. To de-
termine the N-terminal and C-terminal ends of the region
sufficient to substitute for Chi5, new chimeras were generated with
various lengths of V2 in Chi5 swapped with the equivalent of V1.
In Chi11, the main cluster of differences in the N-terminal end of
the V2-specific sequence (119–133) in Chi5 was taken out and was
replaced with the corresponding sequence of V1. In Chi12, dif-
ferences in the C-terminal end of the V2 sequence of Chi5 (180–
188) were eliminated by replacement with the relevant part of V1.
In Chi13, both V2 (119–133) and V2 (18–188) were cut out
and replaced with the relevant fractions of V1 (Fig. S2F). The
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expression and membrane localization of Chi11–Chi13 were
confirmed (Fig. 4C). The Bak level in the membrane fraction and
cyto c release were fully restored in the cells expressing Chi12,
whereas only partial rescue took place in the cells expressing
Chi11 and Chi13 (Fig. 4 C and D). Time lapse monitoring of ΔΨm
in adherent cells showed the same pattern of depolarization for
V2−/− cells expressing Chi12 or V2 after treatment with tBid (Fig.
4H and Fig. S1D). Altogether, these data show that V2 (123–179)
is the shortest sequence that is sufficient for fully supporting the
recruitment of Bak and tBid-induced OMM permeabilization.
Loss-of-Function Mutations in V2: T168 and D170 Are Critical Amino
Acids for Bak Targeting to the OMM. In the next step, we tried to find
the critical residues supporting Bak import. Cutting the C-terminal
part of V2 in Chi5 (162–188) in Chi9 totally abrogated tBid-
induced cyto c release; however, cutting of V2 (180–188) in Chi12
did not change the response. That result led us to hypothesize that
the most critical domain must be located in V2 (162–179). The
location of this sequence at the edge of a β-sheet (β-sheet 10) in
the biophysical model (Fig. 2A) strengthens this idea. In addition,
cells expressing Chi7 and Chi13 show a partial response, and that
result led us to assume that there might be some effective motifs in
the N-terminal part of the V2 sequence in Chi5. Therefore, based
on the differences between V2 and V1, which were conserved in
all species, we made short mutations in the amino acid 122–179
segment of V2. To test the importance of the C terminus, M1, M2,
and M3 were generated in which amino acids 168–176, 168–171,
and 175–176 in V2 were replaced with the equivalent sequence of
V1 in order. On the other hand, to study the effect of the N-ter-
minal segment, M4 was made by the replacing of V2 (123–124)
with the relevant sequence in V1 (Fig. S2G). The presence of
mutant proteins in the membrane fraction of V2−/− cells
expressing V2 (M1–M4) was validated (Fig. 4E and Fig. S1E). Bak
showed an increase in V2−/− cells expressing M3 (Fig. 4E) and M4
(Fig. S1E). By contrast, it did not show any alteration in the cells
expressing M1 and M2. The tBid-induced cyto c release was sig-
nificant in V2−/− cells expressing M3 (similar to the cells rescued
by V2). It was moderate in cells expressing M4, and it was abol-
ished in the cells expressing M1 and M2. Also, tBid induced sig-
nificant depolarization in the V2−/− cells rescued with M3;
however, it failed to change ΔΨm in the cells expressing M2 (Fig. 4
G and H). All of the evidence showed that a small sequence of
threonine (T), phenylalanine (F), aspartic acid (D), serine (S) or
“TFDS” in the position of 168–171 in V2 is critical for Bak in-
sertion and that amino acids serine/glycine (S/G) in the location of
123/124 are also relevant.
In the sequence of TFDS, amino acid F was present both in V1
and V2, so only three amino acids remained to examine. In M5–
M7, T, D, and S were replaced with their equivalent in V1, which
were asparagine (N), glutamic acid (E), and T (Fig. S2H). The
residence of the mutants in the OMM was confirmed in V2−/−
cells expressing M5–M7 (Fig. 5A). To check whether each mu-
tant was inserted into the mitochondria, the subcellular distri-
bution of the mutants was analyzed using immunofluorescence
staining for the HA tag (red in Fig. 5B). V2−/− cells were
cotransfected with GFP-OMP25, an OMMmarker (green in Fig.
5B). In all of the conditions, >90% of the red signal overlapped
with the area of green signal, which means that the HA-tagged
V2 mutant proteins were colocalized with the OMM marker
(Fig. 5C). Bak was increased in the V2−/− MEFs expressing M7
(Fig. 5B); however, it was similar to the negative control in cells
expressing M5 and M6. Furthermore, tBid rapidly released cyto c
and caused collapse of the ΔΨm in cells expressing only M7
(similar to rescued cells with V2) (Fig. 5 D and E). These data
demonstrated that two amino acids, including T168 and D170,
are the most critical amino acids in mV2-mediated support of the
tBid/Bak cell death pathway.
Structural Implications of the Domains Identified by Mutagenesis.
The structure of a mammalian V2 has not been solved. Fortu-
nately, the zfV2 structure has recently become available (37),
and our data showed that zfV2, like mV2, supports the Bak/tBid
pathway (Fig. 2). The regions corresponding to the sufficient
motifs and necessary residues of mV2 are shown in magenta and
yellow, respectively in the zfV2 structure [Protein Data Bank
(PDB) ID code 4bum] (Fig. 6 A and B). The side view in Fig. 6A
shows that T168 (S156 in zfV2) is almost at the end of β-sheet 10
and D170 (D158 in zfV2) is located in the beginning of the loop
between β-sheets 10 and 11. The top view shows that both of the
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necessary residues are on the cytosolic side of the channel and
the side chains of both of these amino acids are facing the inner
side of the pore. The positioning of these amino acids supports
the possibility that the interaction with any other proteins (either
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6 of 10 | www.pnas.org/cgi/doi/10.1073/pnas.1510574112 Naghdi et al.
directly with Bak or a third party needed for Bak) might be af-
fected from the inner side of the channel. Further along this line,
the S171 (T159 in zfV2) that was not critical for Bak re-
cruitment projects to the outer surface.
Next, the crystal structure of zfV2 (111–168) was aligned with
mV1, which cannot support Bak recruitment and has a crystal
structure determined at a similar resolution to zfV2 (36). Comparison
of the crystal structure of zfV2 with mV1 (PDB ID code 3emn)
showed that N156 and E158 in V1 form extensions oriented to-
ward each other to close the gap between them, whereas S156 and
D158 diverge to create an open space in zfV2 (Fig. 6C, Upper
Right). The presence of S156 and D158 in zfV2 also causes dif-
ferences in the proximity of adjacent residues (Fig. 6C, Upper
Left). In Fig. 6C, sticks represent the amino acids that are within a
distance of 4 Å from either S156 or D158 in zfV2 (blue carbons)
or either N156 or E158 in V1 (orange carbons). These adjacent
amino acids have been indicated in the sequences in Fig. 6C
(Lower). Based on the distance between residues in 3D structures,
it seems the loops between β-sheets 10 and 11 and between
β-sheets 9 and 8 in zfV2 are in closer vicinity than the equivalent
loops in mV1. Based on the greater accessibility of the space
defined by the V2-specific critical residues and the differential
arrangement of their neighbors, it is tempting to assume that V2
might provide a more suitable docking site for Bak recruitment.
Notably, the small sequence difference in the highlighted region
seems to result in differential plane positioning of the loop be-
tween β-sheets 10 and 11 relative to the lipid bilayer (Fig. S3)
[predicted by the Orientations of Protein in Membranes (OPM)
database (44)], providing another factor for differential isoform-
specific interaction with other proteins.
Discussion
In this study, we identified by mutational analysis the domain of
V2, which plays a role in mitochondrial Bak import and tBid-
Bak–mediated apoptosis. Although the N-terminal extension
and the higher C content were the suspects previously, we
demonstrated that these unique features of the V2 structure are
dispensable. Our gain-of-function studies revealed that V2 (123–
179) replacement in V1 is sufficient to support the Bak pathway.
Furthermore, loss-of-function studies demonstrated that even a
small change at T168 or D170 of V2 is sufficient to arrest the
Bak pathway and an alteration at S123 or G124 also suppresses
this pathway. Based on the available crystal structure, we predict
that these residues might help to create a potential docking site
for Bak or an adaptor protein. Thus, our findings come together
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to support an unexpected model for the distinctive, and poten-
tially vital, apoptotic function of V2.
Bak and Bax use their C-terminal α-helix (α9) to target the
OMM. Bak is constitutively present in the OMM and mediates the
acute phase of Bid-induced OMM permeabilization, whereas Bax,
which is predominantly cytosolic in healthy cells, inserts and oli-
gomerizes at the OMM more slowly (25, 45). Differently from
other C-terminal anchored proteins, Bak requires V2 for insertion
of its hydrophobic C terminus to the OMM (29), and Bax tar-
geting also seems to depend on the presence of either Bak (the
hetero-oligomerization partner of Bax) or V2 (30). Furthermore,
fusion of the isolated C terminus of Bak to the C terminus of GFP
results in mitochondrial targeting of GFP independent of V2.
Thus, V2 might interact with a remote site on Bak to unmask α9
that would otherwise be unavailable for insertion to the OMM in
the context of the full-length Bak (29, 46). However, how the
structure of V2 supports the interaction with Bak and insertion of
this protein to the OMM had not been investigated.
A mystery, and a unique opportunity for mutational analysis,
was presented by the fact that the three VDAC isoforms display
high sequence similarity, but only V2 can facilitate Bak locali-
zation to the OMM. Thus, to ensure that the β-barrel channel
structure is maintained in the constructs and to avoid protein
misfolding, we did not use deletion and created chimeric con-
structs by V2-specific substitutions in V1 and by V1-specific
substitutions in V2. In addition, because of the lack of an anti-
body that can recognize the chimeras, we decided to use C-ter-
minally HA-tagged constructs. Although a previous work
described mitochondrial toxicity, fragmentation, and a drop in
ΔΨm when C-terminally modified V1 was expressed and raised
concern about C-terminal tagging of β-barrel channels (47), we
did not observe any of the above-described problems and, most
importantly, we had proper mitochondrial localization and res-
cue of function with expression of either V2-HA or nontagged
V2 in V2−/− MEFs.
We first focused on the most striking sequence differences
between V2 vs. V1 and VDAC3, which are the extended N
terminus and the relatively high C content of V2. The possible
role of these V2-specific features was also suggested by the facts
that (i) based on biophysical model, the N terminus is in the pore
(35–39, 41) and might interact with cytoplasmic proteins, and (ii)
the C’s have been implicated in strengthening the channel in-
teraction with their environment and in stabilization of the
channel (48). However, we found that the N-terminal extension
and the surplus C’s are dispensable for Bak import and tBid-
mediated apoptosis (Fig. 2).
The remaining scattered and subtle sequence differences were
evaluated initially with gain-of-function studies, which concluded
that 123–179 is the minimum sequence of V2 sufficient to lend
competency to V1 to target Bak to the OMM (Figs. 3 and 4). If
either the N-terminal or the middle third of this sequence is
switched back to V1, the gain of function is partial, whereas re-
versing back 161–179 to V1 precludes any Bak recruitment and
tBid-induced cyto c release (Fig. 4). When the few isoform-specific
residues in this sequence were further tested in loss-of-function
studies, replacement of V2 (123–124) with the corresponding se-
quence of V1 caused partial loss of function, whereas replacement
of V2 (168–171) led to complete loss of function (Fig. 4). Finally,
point mutations at position T168 or D170 of V2 caused essentially
complete loss of function (Fig. 5). Thus, multiple residues in the
123–179 sequence contribute to formation of the relevant con-
formation, and T168 or D170 is an essential residue.
Because this study is, to our knowledge, the first systematic
mutational analysis of V2, there is little literature to provide a
context for our results. To predict how the essential residues
contribute to a potential protein–protein interaction site, we
considered the available structures. Although mammalian V2 re-
mains to be studied, the structure of zfV2 has just been solved, and
we found that zfV2 rescues Bak import and tBid sensitivity in V2−/−
MEF mitochondria. In zfV2, the sufficient sequence spans from
111 to 167 and the essential residues are S156 and D158 (Table 1).
As Fig. 6 shows, S156 is almost at the end of β-sheet 10 and D158
is located at the beginning of the loop between β-sheets 10 and 11.
This loop is at the cytosolic side of the channel (42), and the side
chains of both of these amino acids are facing the inner side of the
pore, indicating possible interaction with cytoplasmic proteins
(either directly with Bak or with an adaptor) from the inner side of
the channel. Consistent with the proposed relevance of the inner
surface, mutation of S171 in mV2, the equivalent of T159, whose
side chain in mV1 is directed to the outer surface of the channel,
did not affect Bak recruitment. Interestingly, S123 and G124 (S111
and G112 in zfV2), the replacement of which by V1-specific resi-
dues caused partial loss of Bak-related activity (M4 mutant in Fig.
4), are also at the cytoplasmic end of a β-sheet (β-sheet 7) (Fig. 6A,
marked as 111) and so are well positioned to contribute to the
formation of a surface domain that supports Bak recruitment.
Because the structures of both zfV2 and mV1 are available at
very similar resolutions, we could examine the structural differ-
ence caused by the critical residues. Despite the similarity between
zfV2 and mV1 in the critical amino acids, comparison of the
superimposed structures showed that N156 and E158 in V1 form a
closed area, whereas S156 and D158 in zfV2 form the edge of an
open “cup.” The wider space created by the side chains of S156
and D158 might favor protein–protein interaction. In addition,
this small sequence difference might lead to a change in posi-
tioning of the loop between β-sheets 10 and 11 relative to the lipid
membrane [as has been predicted by the OPM database (44)], and
thereby might affect the affinity for interacting with other proteins.
Notably, a recent computational study concluded that A294 in V2
is the primary residue involved in the interaction with Bak (49).
However, our experiments provided clearcut evidence that the
V2-specific C terminus is not required for rescuing Bak targeting
in V2−/− MEF mitochondria (Fig. 3).
In addition to spatial positioning of the residues, posttransla-
tional modification of T168 or D170 might be the reason for the
competence of V2 to support mitochondrial Bak import. Indeed,
Palaniappan et al. (11) showed that V2 might be a substrate for
O-linked β-N-acetylglucosamination; however, our amino acids
of interest have not been reported as the location for glycosyl-
ation. Furthermore, to study the posttranslational modification
of V2, we used tandem MS of V2-HA enriched by immunopre-
cipitation. Unfortunately, the spectra recorded upon digestion
with both trypsin and endoproteinase Asp-N did not reveal our
segment of interest. Finally, the possibility of V2 phosphorylation
Table 1. Alignment of the “sufficient” sequence of V2 from different species and mV1
V2/V1 in different species Sequences
mV2 123 SGKIKSAYKRECINLGCDVDFDFAGPAIHGSAVFGYEGWLAGYQMT168FD170SAKSKLTRS 179
hV2 122 SGKIKSSYKRECINLGCDVDFDFAGPAIHGSAVFGYEGWLAGYQMT167FD169SAKSKLTRN 178
zfV2 111 SGKVKTAYKREFVNLGCDVDFDFAGPTIHGAAVVGYEGWLAGYQMS156FD158TAKSKMTQN 167
mV1 111 NAKIKTGYKREHINLGCDVDFDIAGPSIRGALVLGYEGWLAGYQMN156FE158TSKSRVTQS 167
Blue highlight shows the necessary amino acids in V2s and their equivalent in mV1.
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was tested by searching the phosphosite database (50). However,
there are no data available for amino acids 132–180 of V2. Lack of
data for this part of V2 might be because of a technical difficulty in
protein enrichment or because conventional trypsin digestion does
not provide fragments covering the sequence of interest. Thus,
testing of the possible role of posttranslational modifications
needs further refinement of the technology.
Collectively, our results have addressed the question of what
V2-specific structural differences allow only this VDAC isoform
to control mitochondrial Bak import and, in turn, the acute phase
of Bid-mediated apoptosis. Beyond the fatal outcome of murine
V2 deletion, the human disease relevance of V2 dysregulation is
supported by multiple protein and gene expression datasets
showing specific V2 up-regulation in human hepatocarcinomas.
Therefore, the structural basis of the V2–Bak interplay might
become important in identifying new drug targets. Furthermore,
it is of interest to find out whether the V2-specific sequence
supporting the Bak pathway is also relevant for the recently no-
ticed interactions of V2 with other proteins, including StAR
and GSK3β.
Materials and Methods
Plasmids. The mV2-HA and human VI (hV1)-HA were cloned into pEYFPN1.
The rest of the constructs were generated using relevant restriction en-
zymes for V2 and V1 sequences (Fig. S4). Cloning was performed using
standard molecular biology methods. All of the clones were confirmed
with sequencing. All of the constructs have been linked to a chemical tag
(human influenza HA), except V2(Δ4C) and V2(C228N). Due to the simi-
larity between hV1 and mV1 (with only four not so different amino acids)
and the accessibility of hV1, we used hV1 in our study. Mitochondrial
matrix targeting sequence linked to YFP, Mitomatrix-YFP (Clontech) and
GFP-OMP25 targeting sequence of OMP25 linked to GFP, GFP-OMP25
(from Manuel Rojo, Université Pierre et Marie Curie, Bordeaux, France)
used as mitochondrial markers and cyto c-GFP have been described pre-
viously (28).
Cell Culture, Transfection, and Electroporation. MEFs were cultured in DMEM
supplemented with 10% (vol/vol) FBS, penicillin and streptomycin, L-gluta-
mine, and nonessential amino acids (Invitrogen). Constructs were introduced
to the cells (4.5–6 * 106 cells per 300 μL) by electroporation using BTX-830
square-pulse generator (BTX) (25). Fluorescence-based sorting was per-
formed 48 h after electroporation using 15–20 * 106 cells cotransfected with
a VDAC construct or pcDNA and Mitomatrix–YFP or GFP-OMP25. Infection
with V2 adenovirus (Vector Biolabs) was done using 200 particles per cell for
36–48 h. For single-cell imaging, 12,000–18,000 cells per well were plated
onto glass-bottomed 96-well plates.
ΔΨm and Cyto c Release Assay in Suspensions of Permeabilized Cells. ΔΨm was
measured in suspensions of permeabilized cells using a fluorometer (Delta
RAM; PTI) with 540-nm excitation and 580-nm emission for TMRM (2 μM)
(25, 51). Briefly, 2.4 mg of cells was resuspended in 1.5 mL of ICM [120 mMKCl,
10 mM NaCl, 1 mM KH2PO4, 20 mM Hepes/Tris (pH 7.2), supplemented with
1 μg/mL each antipain, leupeptin, and pepstatin] and were permeabilized
using digitonin (30–40 μg/mL) for 5 min at 37 °C. Measurements were carried
out in the presence of 2 mMMgATP, 2 mM succinate, and 5 μg/mL oligomycin.
In case of sorted cells, due to the limitation in cell mass, the experiment was
scaled down: 4.5–6 *105 sorted cells were permeabilized in 600 μL of ICM,
divided into four equal aliquots used (i) for time control, (ii and iii) for
treatment with tBid, and (iv) with digitonin (600 μg/mL) as a positive control.
Treatment with recombinant tBid (25 nM) lasted for about 5–7 min. At the end
of the incubation period, the cytosolic and membrane fractions were sepa-
rated by centrifugation at 10,000 × g for 5 min. Pellets were lysed in radio-
immunoprecipitation assay buffer, containing 150 mM NaCl, 1.0% (vol/vol)
Octylphenoxypolyethoxyethanol (IGEPAL), 0.5% sodium deoxycholate, 0.1%
SDS, and 50 mM Tris (pH 8.0; Sigma), and the lysed pellets and cytosol fractions
were used for immunoblotting.
Fluorescent Imaging. Cells were cotransfectedwith the plasmid of interest and
cyto c-GFP, and were preincubated with 2% (wt/vol) BSA containing 25 nM
TMRM for 10–15 min at 37 °C. Then, the cells were washed with prewarmed
sodium-Hepes-EGTA consisting of 120 mM NaCl, 5 mM KCl, 1 mM KH2PO4,
0.2 mM MgCl2, 20 mM NaOH/Hepes, and 0.1 mM EGTA9 (pH 7.4), and were
permeabilized with 40 μg/μL digitonin in ICM at 37 °C. After 5 min, the
permeabilization buffer was replaced with fresh ICM (including 5 μg/mL oli-
gomycin, 2 mM succinate, and 2 mM ATP without digitonin). To study cyto c
release, redistribution of cyto c-GFP from mitochondria to the cytosol was
monitored (51). The imaging was performed at 490/20-nm excitation and 540/
50-nm emission using a ProEM1024 EM-CCD (Princeton Instruments), fitted to
a Leica DMI 6000B inverted epifluorescence microscope. Confocal imaging
experiments were performed using a Zeiss LSM780 system (40× or 20× ob-
jective) (28, 51). The laser source was used for imaging of TMRM at 561-nm
excitation. The computer-controlled motorized stage allowed us to measure
ΔΨm in four different wells simultaneously. During the experiment, 5–8 nM
TMRM was used. Also, at the end of each recording, an uncoupler (5 μM FCCP)
was added. All analysis was done using customized imaging software.
Immunoblotting. Western blotting has been described previously (28). Anti-
bodies used include Anti-Bak (no. 06-536; Millipore) Anti-cyt c (no. 556433;
BD Bioscience), Anti-HA (no. 9110; Abcam), Anti-V2 (no. ab37985; Abcam),
Anti-mtHsp70 (no. MA3-028; Thermo Scientific), and Anti-prohibitin (no.
ab28172; Abcam). Detection of bands was performed on a LI-COR Odyssey
scanner. ImageJ (NIH) was used for quantification of the bands.
Immunocytochemistry. Cells cotransfected with the construct of interest and
GFP-OMP25 were washed with PBS and then were fixed by prewarmed 3.5%
(vol/vol) paraformaldehyde in PBS for 15min at room temperature. Cells were
further permeabilized and blocked with 3% (wt/vol) BSA and 0.1% Tween-20
in PBS for 1 h. They were then incubated for 1 h with Anti-HA antibody in 1%
(wt/vol) BSA and 0.1% Tween-20. Finally, the cells were incubated for 45 min
with Alexa Fluor 647 anti-rabbit secondary antibody (Molecular Probes).
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